Nirman Agri Genetics Ltd. carries a market capitalization of 504.74M, placing it among publicly traded companies globally. Its enterprise value stands at 1.23B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 504.74M |
| Enterprise Value | 1.23B |
Nirman Agri Genetics Ltd. currently has 8.01M shares outstanding.
| Shares Outstanding | 8.01M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Nirman Agri Genetics Ltd. trades at a trailing price-to-earnings ratio of 5.87. The price-to-sales ratio is 0.63, and the price-to-book ratio stands at 3.31.
| PE Ratio | 5.87 |
| PS Ratio | 0.63 |
| PB Ratio | 3.31 |
| P/TBV Ratio | 1.35 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Nirman Agri Genetics Ltd. trades at an EV/EBITDA multiple of 4.74 and an EV/FCF ratio of 7,971.01. The EV/Sales ratio of 0.52 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 4.74 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.52 |
| EV / EBITDA | 4.74 |
| EV / EBIT | 4.74 |
| EV / FCF | 7,971.01 |
Nirman Agri Genetics Ltd. maintains a current ratio of 32.06, meaning it holds 32.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.40, indicating conservative leverage, while an interest coverage ratio of 1,629.50 demonstrates limited ability to service its debt obligations.
| Current Ratio | 32.06 |
| Quick Ratio | 8.25 |
| Debt / Equity | 0.40 |
| Debt / EBITDA | 0.02 |
| Interest Coverage | 1,629.50 |
Nirman Agri Genetics Ltd. posts a return on equity of 79.13 and a return on invested capital of 33.58.
| Return on Equity (ROE) | 79.13 |
| Return on Assets (ROA) | 32.14 |
| Return on Invested Capital (ROIC) | 33.58 |
| Return on Capital Employed (ROCE) | 77.88 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 9.05 |
Over the trailing twelve months, Nirman Agri Genetics Ltd. has paid 7.88M in income taxes, reflecting an effective tax rate of 3.02.
| Income Tax | 7.88M |
| Effective Tax Rate | 3.02 |
Nirman Agri Genetics Ltd.'s stock has declined approximately -77.90667% over the past 52 weeks. The 50-day moving average sits at 48.19, while the 200-day moving average is 75.22.
| Beta (5Y) | N/A |
| 52-Week Price Change | -77.90667% |
| 50-Day Moving Average | 48.19 |
| 200-Day Moving Average | 75.22 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Nirman Agri Genetics Ltd. generated 2.37B in revenue and converted that into 252.86M in net income, yielding earnings per share of 33.52. EBITDA reached 259.12M, while operating income came in at 259.12M.
| Revenue | 2.37B |
| Gross Profit | 313.51M |
| Operating Income | 259.12M |
| Pretax Income | 260.75M |
| Net Income | 252.86M |
| EBITDA | 259.12M |
| EBIT | 259.12M |
| Earnings Per Share (EPS) | 33.52 |
Nirman Agri Genetics Ltd. holds 258.72M in cash and equivalents against 4.39M in total debt, resulting in a net debt position of -254.33M. Total book value stands at 448.20M, with working capital of 973.68M providing operational flexibility.
| Cash & Cash Equivalents | 258.72M |
| Total Debt | 4.39M |
| Net Debt | -254.33M |
| Equity (Book Value) | 448.20M |
| Book Value Per Share | 59.41 |
| Working Capital | 973.68M |
Nirman Agri Genetics Ltd. operates with a gross margin of 13.26, reflecting its pricing power and cost economics. The operating margin of 10.96 and net profit margin of 10.69 provide insight into operational efficiency.
| Gross Margin | 13.26 |
| Operating Margin | 10.96 |
| Pretax Margin | 11.02 |
| Profit Margin | 10.69 |
| EBITDA Margin | 10.96 |
Nirman Agri Genetics Ltd. posts an Altman Z-Score of 32.73, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 32.73 |